SHERBURN GROUP PRACTICE — All Prescriptions & Medications
Practice Code: B82031 | LEEDS, LS25 6ED
Over the last 12 months, SHERBURN GROUP PRACTICE prescribed 228,972 items across 638 different medications at a total cost of £1,873,247 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Codeine phosphate | 10 | 2,000 | £38 | -30.3% ▼ |
| Temazepam | 10 | 140 | £109 | -82.5% ▼ |
| Imipramine hydrochloride | 10 | 1,036 | £40 | -60.8% ▼ |
| Cinnarizine | 10 | 714 | £32 | -78.6% ▼ |
| Almotriptan | 10 | 111 | £251 | -19.3% ▼ |
| Cefuroxime axetil | 10 | 140 | £82 | +352.9% ▲ |
| Norethisterone | 10 | 840 | £20 | -28.5% ▼ |
| Tamsulosin and dutasteride hydrochloride | 10 | 300 | £90 | -71.4% ▼ |
| RtS 2 - 2.4 kcal/ml m/sk lower volume with fibre (0913011) | 10 | 55.5K | £1.2K | -19.4% ▼ |
| Tube feed 1.2 kcal/ml with fibre (0914021) | 10 | 95.5K | £1.6K | -21.3% ▼ |
| Tube feed 1.2 kcal/ml peptide based | 10 | 255.0K | £4.4K | +35.4% ▲ |
| Etodolac | 10 | 300 | £147 | -63.9% ▼ |
| Budesonide | 10 | 10 | £99 | -35.7% ▼ |
| Sodium chloride | 10 | 544 | £313 | -66.4% ▼ |
| 10 | 300 | £757 | -43.3% ▼ | |
| 10 | 240 | £767 | -50.9% ▼ | |
| Finerenone | 11 | 308 | £383 | +1.1% vs avg |
| Pentoxifylline | 11 | 990 | £203 | -12.2% ▼ |
| Pentosan polysulfate sodium | 11 | 990 | £5.0K | +85.2% ▲ |
| Sodium chloride | 11 | 1,100 | £101 | -53.5% ▼ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 11 | 8,520 | £132 | -52.0% ▼ |
| Fusidic acid | 11 | 55 | £221 | +6.5% ▲ |
| Clindamycin/tretinoin | 11 | 330 | £121 | -6.3% ▼ |
| Heparinoid | 11 | 550 | £41 | -15.7% ▼ |
| 11 | 300 | £403 | +13.9% ▲ | |
| 11 | 280 | £202 | -17.2% ▼ | |
| 11 | 13 | £675 | +146.6% ▲ | |
| 11 | 990 | £3.1K | -0.3% vs avg | |
| 11 | 200 | £891 | +41.7% ▲ | |
| 11 | 210 | £1.1K | -7.1% ▼ | |
| 11 | 180 | £1.3K | +25.7% ▲ | |
| Omega-3-acid ethyl esters | 12 | 672 | £325 | -43.2% ▼ |
| Glycopyrronium bromide | 12 | 360 | £314 | -67.8% ▼ |
| Doxepin | 12 | 336 | £1.0K | -7.7% ▼ |
| Mebendazole | 12 | 294 | £18 | +4.8% ▲ |
| Levonorgestrel | 12 | 840 | £21 | +47.6% ▲ |
| Degarelix | 12 | 12 | £1.3K | -30.9% ▼ |
| Lanreotide | 12 | 12 | £9.7K | +30.1% ▲ |
| Zinc sulfate monohydrate | 12 | 840 | £151 | +35.5% ▲ |
| Erythromycin | 12 | 360 | £165 | -11.6% ▼ |
| Amorolfine hydrochloride | 12 | 70 | £88 | -48.0% ▼ |
| Aciclovir | 12 | 48 | £45 | -2.7% ▼ |
| 12 | 820 | £233 | -18.3% ▼ | |
| 12 | 12 | £165 | +39.7% ▲ | |
| 12 | 1,250 | £138 | +64.8% ▲ | |
| Alverine citrate | 13 | 1,172 | £43 | -68.6% ▼ |
| Sennosides | 13 | 3,350 | £60 | -57.9% ▼ |
| Linaclotide | 13 | 364 | £441 | -28.8% ▼ |
| Zinc oxide | 13 | 237 | £33 | -37.2% ▼ |
| Moxonidine | 13 | 364 | £62 | -76.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.